Relationship of admission hematological indexes with myocardial reperfusion abnormalities in acute ST segment elevation myocardial infarction patients treated with primary percutaneous coronary interventions

Canadian Journal of Cardiology

Volumn 25, Issue 6, 2009, Pages

  Maden, Orhan ^a   Kacmaz, Fehmi ^a   Selcuk, Hatice ^a   Selcuk, Mehmet T ^a   Aksu, Tolga ^a   Tufekciolgu, Omac ^a   Senen, Emir K ^a   Balbay, Yucel ^a   Ilkay, Erdogan ^b  

^a Yuksek Ihtisas Heart Education and Research Hospital   (Turkey)

^b Mesa Hospital Cankaya   (Turkey)

Author keywords

Leukocytes; Platelets; Primary percutaneous coronary intervention; Reperfusion

Indexed keywords

FIBRINOGEN; TIROFIBAN;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART RATE; HOSPITAL ADMISSION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PAIN TO BALLOON TIME; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TRANSLUMINAL CORONARY ANGIOPLASTY; BLOOD; DIAGNOSTIC TEST; ELECTROCARDIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; THROMBOCYTE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD PLATELETS; DIAGNOSTIC TESTS, ROUTINE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY;

EID: 67649974225     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70090-X     Document Type: Article

References (30)

1. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
2. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'non-reflow' phenomenon: A predictor of complications and left ventricular remodeling in perfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
3. Frossard M, Fuchs I, Leitner JM, et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 2004;110:1392-7.
4. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size and age determine platelet function independently. Blood 1984;63:1372-5.
5. Karpatkin S. Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest 1969;48:1073-82.
6. Corash L, Tan H, Gralnick HR. Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood 1977;49:71-87.
7. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338:1409-11.
8. Huczek Z, Kochman J, Filipiak KJ, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005;46:284-90.
9. Sezer M, Okcular I, Goren T, et al. Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention. Heart 2007;93:313-8.
10. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499-511.
11. Lucchesi BR. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol 1990;52:561-76.
12. Barron HV, Cannon CP, Murphy SA, et al. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: A thrombolysis in myocardial infarction 10 substudy. Circulation 2000;102:2329-34.
13. Schroder R, Dissmann R, Bruggemann T, et al. Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 1994;24:384-91.
14. De Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001;38:1283-94.
15. Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 1995;26:1657-64.
16. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-62.
17. De Luca G, van't Hof AW, de Boer MJ, et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. Eur Heart J 2004;25:1009-13.
18. Henriques JP, Zijlstra F, Ottervanger JP, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002;23:1112-7.
19. Engler RL, Schmid-Schönbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
20. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: Role of selectins. Circulation 1998;98:1322-8.
21. Lindgren JA, Edenius C. Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer. Trends Pharmacol Sci 1993; 14:351-4.
22. Golino P, Ashton JH, Buja LM, et al. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo: Thromboxane A2 and serotonin are possible mediators. Circulation 1989;79:154-66.
23. Aziz KA, Cawley JC, Treweeke AT, Zuzel M. Sequential potentiation and inhibition of PMN reactivity by maximally stimulated platelets. J Leukoc Biol 1997;61:322-8.
24. Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M. Activation of human platelets by C5a-stimulated neutrophils: A role for cathepsin G. Am J Physiol 1990;258:C1100-7.
25. Ott I, Neumann F-J, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 1996;94:1239-46.
26. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992;79:1201-5.
27. Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991;84:1758-72.
28. Sheridan FM, Cole PG, Ramage D. Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model. Circulation 1996;93:1784-7.
29. Weyrich AS, Ma XY, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-9.
30. De Lemos JA, Antman EM, Gibson CM, et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation 2000;101:239-43.